SK hynix Inc. posted a 3.7% single-day gain on July 14, yet the broader picture is a stock down 13% over the past week and 11% over the past month — a rebound inside a deeper slide that began when the company's own CEO warned the world that 2027 will be memory's worst year ever.
The selloff has been sharp enough to materially reset valuation. The trailing PE now sits near 7x, and EV/EBITDA has compressed to 5.2x, down roughly 0.8x over the past 30 days. Both multiples remain low by global semiconductor standards, and the implied earnings yield — at roughly 14% — signals deep pessimism is already baked into the Seoul price. The mean analyst price target stands near KRW 3.26 million, implying 70% upside from current levels at KRW 1.91 million, though the consensus is a slim two-analyst "hold" sample, and recent analyst changes are absent from the data. The factor score picture is more constructive than the price action suggests: EPS momentum ranks in the 95th percentile over both 30- and 90-day horizons, and the dividend score hits the 97th percentile — though the analyst recommendation differential score sits at a lowly 6th percentile, reflecting how tepidly the Street is positioned.
The borrow market tells a completely different story from the sentiment. Availability is essentially unconstrained — the lending pool has more than 222 million shares available, and availability reads at the data ceiling, meaning there is no pressure from the short side at all. Short interest, as a fraction of free float, is negligible: utilization peaked at 0.81% earlier in the week before easing back to 0.76%. The ORTEX short score has drifted gently higher to 25.7 — still ranking in the 96th percentile for low short pressure across the universe — confirming this is not a stock under any meaningful bear attack. Borrowing cost has risen 35% over the past month to 0.91%, but at sub-1% that remains firmly in "normal" territory, nowhere near the kind of level that would signal a borrow squeeze. Positioning looks remarkably relaxed given the price action.
The week's most intriguing institutional angle is the divergence between global passive flows and the stock's direction. BlackRock added roughly 979,000 shares in the most recent reported period. Capital Research added 692,000. Both are building into the weakness. The controlling shareholder, SK Square, holds 20% and has not moved. Insider activity over the past 90 days nets to a modest positive — a handful of small purchases by group directors at prices between KRW 1.77 million and KRW 2.39 million, clustered in May and June — though the sole material sell was a KRW 2.84 million exit by one group director on June 24, at prices well above where the stock trades today.
On the peer front, the week's divergence is notable. MU gained 4.9% on the day and is up 4.8% on the week. Taiwan-listed peer 2408 surged 11% over the same period. SK Hynix, by contrast, fell 13% for the week before Tuesday's partial recovery. The Seoul share is clearly bearing a disproportionate share of the post-IPO and CEO-warning overhang relative to the rest of the memory complex, even as the group broadly absorbed macro tailwinds.
Q2 earnings land on July 23. The last print produced a negligible one-day move of less than 0.1%, followed by a 5.2% five-day gain — a pattern of initial indifference giving way to a measured rally. Whether that template repeats depends entirely on whether management revisits, softens, or doubles down on the 2027 demand warning, and on whether Q2 HBM shipment volumes come in ahead of a market that has already marked the Seoul stock down hard.
See the live data behind this article on ORTEX.
Open A000660 on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
